Close Menu

NEW YORK – Genomic sequencing firm Personalis reported after the close of the market on Wednesday that its third quarter revenues were up 47 percent year over year, driven by a single sequencing contract.

In its second earnings report after going public in June, the company said it recorded total revenues of $17.2 million compared to $11.7 million in Q3 2018, beating Wall Street analysts' consensus estimate of $15.8 million.

According to Personalis, its ongoing contract with the US Department of Veterans Affairs was the main driver for this quarterly growth.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Sponsored by

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Sponsored by

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.